SUV39H1通过表观遗传调控促进宫颈癌中CCL22-CCR4表达OACSTPCD
SUV39H1-mediated epigenetic regulation enhances CCL22-CCR4 expression in cervical cancer
目的 探索宫颈癌中C-C基序趋化因子配体22(CCL22)和CC趋化因子受体4(CCR4)的表观遗传调控机制及在宫颈癌发生中的作用.方法 收集宫颈癌组织标本16例,正常宫颈组织标本16例,RT-qPCR法和MS-PCR法分别检测宫颈癌及正常宫颈组织中CCL22和CCR4 mRNA表达水平及其基因启动子DNA甲基化水平.SiHa和HeLa细胞使用不同浓度的5-Aza(DNA甲基转移酶抑制剂,0,2.5,5 μmol/L)处理后,RT-qPCR法检测细胞中CCL22和CCR4 mRNA水平.宫颈癌SiHa和HeLa细胞分别转染过表达组蛋白甲基转移酶SUV39H1的慢病毒表达载体及对照质粒,命名为SUV39H1-OE组和SUV39H1-NC组;并转染SUV39H1特异性siRNA和对照siRNA,命名为siSUV39H1组和siNC组.RT-qPCR法检测SiHa和HeLa细胞中CCL22和CCR4 mRNA表达改变,MS-PCR法检测CCL22和CCR4基因启动子甲基化程度,染色质免疫共沉淀法检测SUV39H1介导的H3K9me3在CCL22和CCR4基因启动子处的富集程度.结果 与正常宫颈组织相比,CCL22和CCR4 mRNA在宫颈癌组织中高表达(P<0.05),其编码基因启动子处呈低甲基化状态(P<0.05).SiHa和HeLa细胞中CCL22和CCR4基因启动子处呈现部分甲基化状态,细胞经去甲基化处理后CCL22和CCR4 mRNA表达水平随浓度增加(P<0.05).与SUV39H1-NC组相比,SUV39H1-OE组宫颈癌细胞中CCL22和CCR4 mRNA表达增加(P<0.05),基因启动子甲基化程度降低(P<0.05).与siNC组相比,siSUV39H1组CCL22和CCR4 mRNA表达降低(P<0.05),基因启动子甲基化程度升高(P<0.05).染色质免疫共沉淀结果显示,SiHa和HeLa细胞中CCL22-CCR4基因启动子区域均有H3K9me3富集(P<0.05).结论 宫颈癌中SUV39H1-H3K9me3参与趋化因子CCL22及其受体CCR4的表观遗传调控.
Objective To investigate the mechanism of epigenetic regulation of C-C-motif ligand 22(CCL22)and CC-chemokine receptor 4(CCR4)in cervical cancer and their roles in cervical carcinogenesis.Methods CCL22 and CCR4 mRNA levels and DNA methylation levels of their gene promoters were detected in 16 cases of cervical cancer and 16 cases of normal cervical tissues by RT-qPCR and MS-PCR,respectively.SiHa and HeLa cells were treated with different concentrations of 5-Aza,a DNA methyltransferase inhibitor(0,2.5,5 μmol/L),and then RT-qPCR was used to detect the expression levels of CCL22 and CCR4 mRNA in these cells.Cervical cancer SiHa and HeLa cells were transfected with a lentiviral expression vector overexpressing the histone methyltransferase(SUV39H1)and a control plasmid,named as SUV39H1-OE group and SUV39H1-NC group.SiHa and HeLa cells were transfected with SUV39H1-specific siRNA and control siRNA,respectively,named as siSUV39H1 group and siNC group.Then RT-qPCR was used to detect the changes of CCL22 and CCR4 mRNA expression in SiHa and HeLa cells,and MS-PCR was used to detect the methy-lation levels of CCL22 and CCR4 gene promoters in these cells.Chromatin immunoprecipitation was used to detect the enrichment of H3K9me3 mediated by SUV39H1 at CCL22 and CCR4 gene promoters.Results The expresions of CCL22 and CCR4 mRNA were significantly higher in cervical cancer tissues than those in normal cervical tissues(P<0.05),and the methylation levels at their gene promoters were lower(P<0.05).The promoters of CCL22 and CCR4 genes showed partial methylation in SiHa and HeLa cells.After de-methylation treatment,the expression levels of CCL22 and CCR4 mRNA were increased in a concentration-dependent manner(P<0.05).Compared with SUV39H1-NC group,CCL22 and CCR4 mRNA expressions in cervical cancer cells were increased in SUV39H1-OE group and the promoter methylation was decreased(P<0.05).Compared with siNC group,CCL22 and CCR4 mRNA expressions were decreased in siSUV39H1 group,and the promoter methylation was increased(P<0.05).Chromatin immunoprecipitation showed H3K9me3 enrichment in the CCL22-CCR4 gene promoter regions in SiHa and HeLa cells(P<0.05).Conclusion SUV39H1-H3K9me3 is involved in the epigenetic regulation of the chemokine CCL22 and its receptor CCR4 in cervical cancer cells.
张力;高艳娥;梁嘉伟;盛佩婷
西安交通大学第二附属医院妇产科,西安 710004
临床医学
宫颈癌SUV39H1组蛋白甲基化DNA甲基化表观遗传调控CCL22-CCR4
cervical cancerSUV39H1histone methylationDNA methylationepigenetic regulationCCL22-CCR4
《山西医科大学学报》 2024 (009)
1113-1121 / 9
陕西省自然科学基础研究计划项目(2023-JC-QN-0901)
评论